EurekAlert! -
23 Jul 2019 06:00
(The Familial Hypercholesterolemia Foundation) Individuals at high risk for cardiovascular events had more heart attacks, strokes and other cardiovascular events when they were unable to obtain their prescribed LDL-cholesterol lowering medication. In a new study in Circulation: Cardiovascular Quality and Outcomes, researchers with the FH Foundation found that individuals with familial hypercholesterolemia (FH) or atherosclerotic heart disease (ASCVD) whose PCSK9 inhibitors (PCSK9is) were rejecte...
Share this Article